rs199422123
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM1BP4_ModerateBS2_Supporting
The NM_002769.5(PRSS1):c.361G>A(p.Ala121Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151978Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250602Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135548
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461880Hom.: 0 Cov.: 61 AF XY: 0.0000536 AC XY: 39AN XY: 727242
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151978Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74238
ClinVar
Submissions by phenotype
Hereditary pancreatitis Uncertain:3
The p.A121T variant (also known as c.361G>A), located in coding exon 3 of the PRSS1 gene, results from a G to A substitution at nucleotide position 361. The alanine at codon 121 is replaced by threonine, an amino acid with similar properties. This alteration was first described in an individual with pancreatitis; however, four family members who carried this variant did not have pancreatitis. The same study found this variant resulted in an increased rate of trypsin cleavage (Felderbauer P et al. J. Med. Genet. 2008; 45:507-12). One study found a significant correlation between individuals who carried this alteration and pancreatitis (Liu QC et al. Chin. Med. J. 2008; 121:108-11). However, an additional study found this variant had no effect on auto-activation, degradation, secretion, or kinetic parameters of trypsin (Szmola R and Sahin-Tóth M J. Med. Genet. 2010; 47:348-50). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 121 of the PRSS1 protein (p.Ala121Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with chronic pancreatitis (PMID: 16791840, 18272034, 18511571, 20001681). ClinVar contains an entry for this variant (Variation ID: 11885). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRSS1 protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PRSS1 function (PMID: 18511571, 20452997). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant summary: PRSS1 c.361G>A (p.Ala121Thr) results in a non-conservative amino acid change located in the Serine proteases, trypsin domain (IPR001254) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 250602 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.361G>A has been reported in the literature in individuals affected with Chronic Pancreatitis, however does not appear to segregate with the disease (examples: Felderbauer_2008, Liu_2008, Liu_PRSS1_2009 and Szmola_2010) . These report(s) do not provide unequivocal conclusions about association of the variant with Chronic Pancreatitis. Multiple publications have reported experimental evidence evaluating an impact on protein function. These results showed conflicting asessments on variant function (example: Felderbauer_2008 and Szmola_2010). The following publications have been ascertained in the context of this evaluation (PMID: 18511571, 20001681, 18272034, 20452997 ). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
Published functional studies demonstrate no impact on autoactivation or secretion rates and conflicting results on degradation (Felderbauer 2008, Szmola 2010); Observed in individuals with a personal history of pancreatitis, but also in unaffected relatives (Felderbauer 2008, Liu 2008); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 18511571, 20452997, 18272034, 18946221, 20001681, 16791840) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at